BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

LifeScience Emerging Biotech

CelluPro Becomes First Chinese Cell Culture Media Supplier to Secure EXCiPACT GMP Certification

CelluPro, a biotechnology company specializing in serum-free cell culture media and bioprocess solutions, has achieved EXCiPACT™ GMP Certif...

September 09, 2026 | News

Rznomics Advances High-Efficiency Circular RNA Production with Engineered STS Technology

Rznomics Inc.(KOSDAQ: 476830), a biopharmaceutical company specializing in the development of RNA-based gene therapies, announced a major breakthrough in t...

September 08, 2026 | News

AstraZeneca Secures US FDA Approval for ETCAMAH Combination in Advanced Breast Cancer

Approval based on SERENA-6 Phase III trial results which showed combination reduced the risk of disease progression or death by 56% in patients with an e...

September 08, 2026 | News

Novonesis Invests €600M to Expand Enzyme Production Facility in India

Novonesis will expand its facility in Patalganga and build one of the world's most advanced enzyme production facilities. The €600 million investment ...

September 07, 2026 | News

DualityBio, Genentech Ink $1B-Plus Deal to Develop Next-Generation ADCs Against Drug-Resistant Tumours

Collaboration leverages DualityBio's proprietary DUPAC payload platform and early global clinical development capabilities, with Genentech assuming furth...

August 31, 2026 | News

PENTAX Medical, MAGENTIQ EYE Expand AI-Assisted Colonoscopy Partnership Globally

Expanded agreement combines PENTAX Medical's continued investment in flexible reusable endoscopy with MAGENTIQ's clinically validated AI capabilities, expa...

August 28, 2026 | News

South Korea’s Rznomics Joins Lilly Gateway Labs in US to Accelerate RNA Gene Therapies

Rznomics Inc.(KOSDAQ: 476830), a biopharmaceutical company specializing in the development of RNA-based gene therapies, announced that it is joining Lilly ...

August 25, 2026 | News

Kyowa Kirin Taps Cognizant and Benchling to Build AI-Powered Drug Discovery Foundation in Japan

Cognizant announced that it will support the introduction and implementation of Benchling, the AI platform for R&D at Tokyo Research Park and Fuji Rese...

August 18, 2026 | News

IASO Bio Acquires Singapore’s MediSix Therapeutics to Strengthen Global Cell Therapy Platform

- IASO Biotechnology announced the completion of its acquisition of MediSix Therapeutics , a Singapore-based immune cell engineering and cell therapy compa...

August 17, 2026 | News

ArkBio’s Long-Acting Influenza Candidate AK0406 Secures IND Approval in China

Shanghai Ark Biopharmaceutical Co., Ltd. announced that the Investigational New Drug (IND) application for AK0406 injection, the company's first long-actin...

August 14, 2026 | News

Kelun-Biotech's TROP2 ADC sac-TMT Advances Toward First-Line TNBC Approval in China

Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. ("Kelun-Biotech" or the "Company", 6990.HK) announced that a new indication application of its trophoblas...

August 03, 2026 | News

CellOrigin Advances In Vivo Cell Therapy Pipeline with ASCO Data and Walvax Partnership

CellOrigin, a biotechnology company focused on next-generation in vivo and in vitro cell therapy technologies, has announced two major progresses in b...

August 03, 2026 | News

Ractigen Therapeutics Raises Over $31 Million to Advance saRNA Drug Pipeline

Ractigen Therapeutics, a clinical-stage biotechnology company pioneering small activating RNA (saRNA) therapeutics and advanced extrahepatic delivery syste...

July 31, 2026 | News

12 Funding Rounds That Show Where APAC Biotech Capital Is Going

There is a version of this story that lists twelve press releases and calls it analysis. This is not that story. Every round below has already been announc...

July 30, 2026 | News

Stay Connected